Genetics of spondyloarthritis - Beyond the MHC

Nature Reviews Rheumatology

Volumn 8, Issue 5, 2012, Pages 296-304

  Reveille, John D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARD9 GENE; CYTOKINE PRODUCTION; ENTERITIS; ENVIRONMENTAL FACTOR; ERAP1 GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; HLA B GENE; HLA B27 GENE; HUMAN; INTERLEUKIN 1 GENE; INTERLEUKIN 1 RECEPTOR 2 GENE; INTERLEUKIN 12B GENE; INTERLEUKIN 23 RECEPTOR GENE; KIF21B GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; PTGER4 GENE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RUNX3 GENE; SPONDYLARTHRITIS; STAT GENE; TUMOR NECROSIS FACTOR GENE;

ARTHRITIS, PSORIATIC; CYTOKINES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HLA-C ANTIGENS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; MALE; PSORIASIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING;

EID: 84860585350     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2012.41     Document Type: Review

References (107)

1. Schlosstein, L., Terasaki, P. I., Bluestone, R., Pearson, C. M. High association of an HLA antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 288, 704-706 (1973)
2. Murray, C. et al. Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J. Clin. Invest. 66, 670-675 (1980)
3. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001)
4. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001)
5. Brown, M. A. et al. Susceptibility to ankylosing spondylitis in twins: The role of genes, HLA, and the environment. Arthritis Rheum. 40, 1823-1828 (1997)
6. Brown, M. A., Laval, S. H., Brophy, S. & Calin, A. Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 59, 883-886 (2000)
7. Brown, M. A. Progress in the genetics of ankylosing spondylitis. Brief Funct. Genomics 10, 249-257 (2011)
8. Dangoria, N. S. et al. HLA B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 277, 23459-23468 (2002)
9. Delay, M. L. et al. HLA B27 misfolding and the unfolded protein response augment interleukin 23 production and are associated with TH17 activation in transgenic rats. Arthritis Rheum. 60, 2633-2643 (2009)
10. Kollnberger, S. et al. Cell-surface expression and immune receptor recognition of HLA B27 homodimers. Arthritis Rheum. 46, 2972-2982 (2002)
11. Campbell, E. C., Fettke, F., Bhat, S., Morley, K. D. & Powis, S. J. Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort. Immunology 133, 379-385 (2011)
12. Mathieu, A. et al. The interplay between the geographic distribution of HLA B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis. Autoimmun. Rev. 8, 420-425 (2009)
13. Gerard, H. C., Branigan, P. J., Schumacher, H. R. & Hudson, A. P. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J. Rheumatol. 25, 734-742 (1998)
14. van Der Linden, S. M., Valkenburg, H. A., De Jongh, B. M. & Cats, A. The risk of developing ankylosing spondylitis in HLA B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 27, 241-249 (1984)
15. Robinson, W. P. et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA B27+ patients. Arthritis Rheum. 32, 1135-1141 (1989)
16. Brown, M. A. et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis. 55, 268-270 (1996)
17. Wei, J. C., Tsai, W. C., Lin, H. S., Tsai, C. Y. & Chou, C. T. HLA B60 and B61 are strongly associated with ankylosing spondylitis in HLA B27 negative Taiwan Chinese patients Rheumatology (Oxford) 43, 839-842 (2004)
18. Reveille, J. D. The genetic basis of spondyloarthritis. Ann. Rheum. Dis. 70 (Suppl. 1), i44-i50 (2011)
19. Evans, D. M. et al. Interaction between ERAP1 and HLA B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA B27 in disease susceptibility. Nat. Genet. 43, 761-767 (2011)
20. Wellcome Trust Case Control Consortium et al. Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity. Nat. Genet. 39, 1329-1337 (2007)
21. Australo Anglo American Spondyloarthritis Consortium et al. Genomewide association study of ankylosing spondylitis identifies multiple non-MHC susceptibility loci. Nat. Genet. 42, 123-127 (2010)
22. Maksymowych, W. P. et al. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum. 60, 1317-1323 (2009)
23. Tsui, F. W. et al. Association of an ERAP1/ ERAP2 haplotype with familial ankylosing spondylitis. Ann. Rheum. Dis. 69, 733-736 (2010)
24. Pimentel-Santos, F. M. et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin. Exp. Rheumatol. 27, 800-806 (2009)
25. Paźr, B. et al. Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: The rs27044 variant is associated with HLA B. *2705 subtype in Hungarian patients with ankylosing spondylitis. J. Rheumatol. 37, 379-384 (2010)
26. Davidson, S. I. et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 60, 3263-3268 (2009)
27. Bang, S. Y. et al. Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patients. J. Rheumatol. 38, 322-324 (2011)
28. Yan, J. et al. In vivo role of ER associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J. Exp. Med. 203, 647-659 (2006)
29. Genetic Analysis of Psoriasis Consortium and the Wellcome Trust Case Control Consortium 2. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA C and ERAP1. Nat. Genet. 42, 985-990 (2010)
30. Kochan, G. et al. Crystal structures of the endoplasmic reticulum aminopeptidase 1 (ERAP1) reveal the molecular basis for N terminal peptide trimming. Proc. Natl Acad. Sci. USA 108, 7745-7750 (2011)
31. Cui, X. et al. Identification of ARTS 1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J. Clin. Invest. 110, 515-526 (2002)
32. Haroon, N., Tsui, F. W., Chiu, B., Tsui, H. W. & Inman, R. D. Serum cytokine receptors in ankylosing spondylitis: Relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. J. Rheumatol. 37, 1907-1910 (2010)
33. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006)
34. Cargill, M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273-290 (2007)
35. Karaderi, T. et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-Analysis of published series. Rheumatology (Oxford) 48, 386-389 (2009)
36. Rahman, P. et al. Association of interleukin 23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 58, 1020-1025 (2008)
37. Rueda, B. et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 67, 1451-1454 (2008)
38. Safrany, E. et al. Interleukin 23 receptor gene variants in Hungarian systemic lupus erythematosus patients. Inflamm. Res. 59, 159-164 (2010)
39. Sung, I. H. et al. IL 23R polymorphisms in patients with ankylosing spondylitis in Korea. J. Rheum. 236, 1003-1005 (2009)
40. Davidson, S. I. et al.Association of STAT3 and TNFSF1A with ankylosing spondylitis in Han Chinese. Ann. Rheum. Dis. 70, 289-292 (2011)
41. Kugathasan, S. et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 40, 1211-1215 (2008)
42. McGarry, F., Neilly, J., Anderson, N., Sturrock, R. & Field, M. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 40, 1359-1364 (2001)
43. van Der Paardt, M. et al. Interleukin-1β and interleukin 1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) 41, 1419-1423 (2002)
44. Maksymowych, W. P. et al. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-Assisted laser desorption ionization time of-flight mass spectrometry. Arthritis Rheum. 48, 2011-2018 (2003)
45. Chou, C. T. et al. Replication of association of IL 1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann. Rheum. Dis. 65, 1106-1109 (2006)
46. Timms, A. E. et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am. J. Hum. Genet. 75, 587-595 (2004)
47. Sims, A. M. et al. Prospective meta-Analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann. Rheum. Dis. 67, 1305-1309 (2008)
48. Haibel, H., Rudwaleit, M., Listing, J. & Sieper, J. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann. Rheum. Dis. 64, 296-298 (2005)
49. Dowling, O. et al. Mutations in capillary morphogenesis gene 2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am. J. Hum. Genet. 73, 957-966 (2003)
50. Park, J. H. et al. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat. Immunol. 11, 257-264 (2010)
51. Gottlieb, A. et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial. Lancet 373, 633-640 (2009)
52. Danoy, P. et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet. 6, e1001195 (2010)
53. Armaka, M. et al. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med. 205, 331-337 (2008)
54. Bouwmeester, T. et al. A physical and functional map of the human TNF-A/NF ? B signal transduction pathway. Nat. Cell Biol. 6, 97-105 (2004)
55. Pointon, J. J. et al.The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-Associated death domain (TRADD). Ann. Rheum. Dis. 69, 1243-1246 (2010)
56. Pointon, J. J. et al. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun. 11, 490-496 (2010)
57. Ruland, J. CARD9 signaling in the innate immune response. Ann. NY Acad. Sci. 1143, 35-44 (2008)
58. LeibundGut-Landmann, S. et al. Syk-And CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638 (2007)
59. Gagliardi, M. C. et al. Endogenous PGE2 promotes the induction of human TH17 responses by fungal β glucan. J. Leukoc. Biol. 88, 947-954 (2010)
60. Dekker-Saeys, AJ, Keat, A. Follow-up study of ankylosing spondylitis over a period of 12 years (1977-1989). Scand. J. Rheumatol. 87 (Suppl.), 120-121(1990)
61. Gudjónsson J, E, et al. HLA Cw6 positive and HLA Cw6 negative patients with psoriasis vulgaris have distinct clinical features. J. Invest. Dermatol. 118, 362-365 (2002)
62. Nair, R. P. et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60 kb interval telomeric to HLA C. Am. J. Hum. Genet. 66, 1833-1844 (2000)
63. Nair, R. P. et al. Sequence and haplotype analysis supports HLA C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78, 827-851 (2006)
64. Feng, B. J. et al. Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet. 5, e1000606 (2009)
65. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999)
66. Reischl, J. et al. Increased expression of Wnt5a in psoriatic plaques. J. Invest. Dermatol. 127, 163-169 (2007)
67. Elder, J. T. Genome-wide association scan yields new insights into the immuno-pathogenesis of psoriasis. Genes Immun. 10, 201-209 (2009)
68. Nair RP. et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J. Invest. Dermatol. 128, 1653-1661 (2008).
69. Lesueur, F. et al. ADAM33, a new candidate for psoriasis susceptibility. PLoS ONE 2, e906 (2007)
70. Liu, Y. et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4, e1000041 (2008)
71. Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL 23 and NF ?B pathways. Nat. Genet. 41, 199-204(2009)
72. Stuart, P. E. et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat. Genet. 42, 1000-1004 (2010)
73. Li, Y. et al. Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. J. Invest Dermatol. 129, 629-634 (2009)
74. Sun, L. D. et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42, 1005-1009 (2010)
75. Ellinghaus, E. et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat. Genet. 242, 991-995 (2010)
76. Hüffmeier, U. et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat. Genet. 42, 996-999 (2010)
77. Qian, Y. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247-256 (2007)
78. Zhang, X. J. et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 41, 205-210 (2009)
79. De Cid, R. et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 41, 211-215 (2009)
80. Pollock, R. et al. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens 77, 554-561(2011)
81. Rahman, P. et al. High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis. Ann. Rheum. Dis. 70, 690-694 (2011)
82. Rahman, P. et al. Association between the interleukin 1 family gene cluster and psoriatic arthritis. Arthritis Rheum. 54, 2321-2325 (2006)
83. Ravindran, J. S. et al. Interleukin 1a, interleukin 1β and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 43, 22-26 (2004)
84. Bowes, J. et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann. Rheum. Dis. 70, 1641-1644 (2011)
85. Duffin, K. C. et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J. Invest. Dermatol. 129, 2777-2783 (2009)
86. Bowes, J. et al. Evidence to support IL 13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann. Rheum. Dis. 70, 1016-1019 (2011)
87. Bowes, J. et al. Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Ann. Rheum. Dis. 69, 2199-2203 (2010)
88. Huffmeier, U. et al. Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients. Ann. Rheum. Dis. 69, 876-878 (2010)
89. Mielants, H. et al. Gut inflammation in the spondyloarthropathies: Clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J. Rheumatol. 18, 1542-1551 (1991)
90. Cooney, R. et al. A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16, 90-97, (2010)
91. Rioux, J. D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007)
92. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007)
93. Wang, K. et al., Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease. Am. J. Hum. Genet. 84, 399-405 (2009)
94. Barrett, J. C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008)
95. Fisher, S. A. et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40, 710-712 (2008)
96. Franke, A. et al. Genome-wide meta-Analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010)
97. McGovern, D. P. B. et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42, 332-337 (2010)
98. Anderson, C. A. et al. Meta-Analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43, 246-252 (2011)
99. Festen, E. A. et al. A meta-Analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet. 7, e1001283 (2011)
100. Brest, P.et al. A synonymous variant in IRGM alters a binding site for miR 196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat. Genet. 43, 242-245 (2011)
101. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40, 1107-1112 (2008)
102. Waterman, M. et al. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: Correlations with pathogenesis. Inflamm. Bowel Dis. 17, 1936-1942 (2010)
103. Laukens, D. et al. Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis. PLoS ONE 5, e13795 (2010)
104. Momozawa, Y. et al. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat. Genet. 43, 43-47 (2011)
105. Fellermann, K. et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79, 439-448 (2006)
106. Hollox, E. J. et al. Psoriasis is associated with increased β-defensin genomic copy number. Nat. Genet. 40, 23-25 (2008)
107. Kang, J. et al. The NIDDK IBD Genetics Consortium. Improved risk prediction for Crohn's disease with a multi-locus approach. Hum. Mol. Genet. 20, 2435-2442 (2011)